Informazioni sul prodotto
- 2-(4-Butoxyphenyl)Acetohydroxamic Acid
- 2-(4-butoxyphenyl)-N-hydroxyacetamide
- 2-(p-Butoxyphenyl)acetohydroxamic acid
- 4-Butoxy-N-hydroxybenzeneacetamide
- 4-Butoxyphenylacethydroxamic acid
- Acetohydroxamic acid, 2-(p-butoxyphenyl)-
- Anderm
- Benzeneacetamide, 4-butoxy-N-hydroxy-
- Bufexamic acid
- Cp 1044J3
- Vedi altri sinonimi
- Droxarol
- Droxaryl
- Feximac
- Flogocid
- Flogocid N plastigel
- Malipuran
- Mofenar
- Norfemac
- Parfenac
- Parfenal
- Trolab
- p-Butoxyphenylacethydroxamic acid
- p-Butoxyphenylacetohydroxamic acid
Bufexamac is a non-steroidal antiinflammatory drug that belongs to the class of pyridyl-2-one derivatives. It inhibits matrix metalloproteinase (MMP) activity and has been shown to inhibit the activity of MMP-9 in a statistically significant manner. Bufexamac also binds to DNA, inhibiting bacterial growth by binding to dna binding activity. In addition, bufexamac nanoparticulate compositions have been shown to have uv absorption and can be used for diagnosis. The antioxidative properties of bufexamac may reduce cancer risk and inflammatory skin diseases such as psoriasis. Bufexamac has been shown to be an effective treatment for chronic schizophrenia and other mental illnesses with high body mass index. Further, bufexamac has been found to bind specifically to the enzyme responsible for fragmentation of amyloid precursor protein (APP).
Proprietà chimiche
Richiesta tecnica su: 3D-CAA43872 Bufexamac
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
